Novel plant-based drug now available for the treatment of chemotherapy-induced diarrhea in dogs
Jaguar Animal Health’s crofelemer product has conditional approval from the FDA
Draft guidance for use of published literature to support new animal drug approvals announced by FDA
The document expands upon the original guidance #106 by considering various uses of the scientific literature to support approval of a new animal drug
Final guidance on animal drug compounding from bulk drug substances issued by the FDA
The agency will provide outreach and education as part of its’ implementation plan.
3 Must-reads on recent FDA approvals
3 articles highlighting the latest FDA-approved veterinary drugs
FDA approves new combination injection for sedation and pain relief in dogs
The drug product is a balanced combination of medetomidine and vatinoxan.
First generic firocoxib chewable tablets approved by the FDA for dogs
The new drug product is indicated for dogs with pain and inflammation associated with osteoarthritis, and postoperative pain and inflammation associated with soft-tissue and orthopedic surgery.
FDA approves 2 antibiotics for treating swine respiratory disease
The new prescription drugs from Merck Animal Health are broad-spectrum medications for combating organisms that cause the illness.
Jaguar Animal Health seeks MUMS designation from FDA to expand canine diarrhea treatment
Crofelemer (Canalevia-CA1) is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs and could also be used to treat exercise-induced diarrhea.
First monoclonal antibody for animals approved by FDA to control pain in cats
Frunevetmab injection (Zoetis; Solensia) is the first treatment for pain associated with osteoarthritis in cats.
FDA guidance promotes antimicrobial stewardship through increased veterinary oversight
Antimicrobial stewardship has taken the human health world by storm, and now, it’s securing its place in veterinary medicine.
2 Commerce Drive Cranbury, NJ 08512